JPH03197477A - Substances fo-608b and c and its production - Google Patents

Substances fo-608b and c and its production

Info

Publication number
JPH03197477A
JPH03197477A JP33709289A JP33709289A JPH03197477A JP H03197477 A JPH03197477 A JP H03197477A JP 33709289 A JP33709289 A JP 33709289A JP 33709289 A JP33709289 A JP 33709289A JP H03197477 A JPH03197477 A JP H03197477A
Authority
JP
Japan
Prior art keywords
substance
culture
substances
penicillium
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP33709289A
Other languages
Japanese (ja)
Other versions
JP2872311B2 (en
Inventor
Satoshi Omura
智 大村
Hiroshi Koda
洋 供田
Hiroyuki Nishida
博之 西田
Rokurou Masuma
碌郎 増間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Institute filed Critical Kitasato Institute
Priority to JP1337092A priority Critical patent/JP2872311B2/en
Publication of JPH03197477A publication Critical patent/JPH03197477A/en
Application granted granted Critical
Publication of JP2872311B2 publication Critical patent/JP2872311B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

NEW MATERIAL:Substances FO-608B expressed by formula I and FO-608C expressed by formula II or salts thereof. USE:A treating agent, having inhibitory activity against acylcoenzyme A cholesterol acyltransferase and useful for hyperlipemia and adult diseases such as arteriosclerosis caused thereby. PREPARATION:A mirroorganism, belonging to the genus Penicillium and having the ability to produce the substance FO-608B or FO-608C or both thereof is cultured in a culture medium to accumulate the substance FO-608B or FO-608C or both thereof in the resultant culture. The above-mentioned substances are then collected from the culture. The culture is normally carried out in a nutrient culture medium containing carbon sources, nitrogen sources, etc., capable of being anabolized or assimilated by the microorganism according to a method for culturing fungi.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、アシルコエンザイムAコレステロールアシル
転位酵素阻害を有する新規物質FO−608物質類およ
びその製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to novel FO-608 substances that inhibit acyl-coenzyme A cholesterol acyltransferase and a method for producing the same.

〔従来の技術〕[Conventional technology]

従来、いくつかの高脂血症薬物が知られていたが、未だ
に有効な物質は得られていない。
Although several hyperlipidemia drugs have been known, no effective substance has been obtained yet.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

近年、食生活の向上に伴い成人の高脂血症や動脈硬化な
どコレステロール蓄積に起因する症状が現代病として問
題視されている。コレステロールはアシルコエンザイム
Aからアシル基転位によりコレステロールエステルとな
り、細胞内および血中リボ蛋白に蓄積される。このアシ
ル基転位反応を触媒する酵素がアシルコAエンザイムA
コレステロールアシル転位酵素であり、コレステロール
の腸管からの吸収および冠動脈における泡沫細胞の形成
に深く係わっている。したがって、アシルコエンザイム
Aコレステロールアシル転位酵素を阻害する物質は、か
かる疾病に有効であることが推察される。
In recent years, as dietary habits have improved, symptoms caused by cholesterol accumulation, such as hyperlipidemia and arteriosclerosis in adults, have become problematic as modern diseases. Cholesterol becomes cholesterol ester by acyl group rearrangement from acyl coenzyme A, and is accumulated in cells and in blood riboproteins. The enzyme that catalyzes this acyl group transfer reaction is acylco-A enzyme A.
It is a cholesterol acyltransferase and is deeply involved in the absorption of cholesterol from the intestinal tract and the formation of foam cells in coronary arteries. Therefore, it is presumed that substances that inhibit acyl-coenzyme A cholesterol acyltransferase are effective against such diseases.

かかる実情において、アシルコエンザイムAコレステロ
ールアシル転位酵素阻害活性を有する物質を提供するこ
とは、高脂血症やそれに暴く動脈硬化などの成人病の治
療上有用なことである。
Under these circumstances, providing a substance having acyl-coenzyme A cholesterol acyltransferase inhibitory activity is useful in the treatment of adult diseases such as hyperlipidemia and arteriosclerosis that are exposed thereto.

〔課題を解決するだめの手段〕[Failure to solve the problem]

本発明者らは、微生物の生産する代謝産物に付いて研究
を続けた結果、新たに土壌から分離したF0608菌株
の培養物中にアシルコエンザイムAコレステロールアシ
ル転位酵素阻害活性を有する物質が産生されることを見
出した。次いで、該培養物からアシルコエンザイムAコ
レステロールアシル転位酵素阻害活性物質を分離、精製
した結果、このような化学構造を有する物質は従来全く
知られていないことから、本物質をFO160B物質B
およびF0608C物質と称することにした。
As a result of continuing research on metabolites produced by microorganisms, the present inventors discovered that a substance with acyl-coenzyme A cholesterol acyltransferase inhibitory activity was produced in a culture of strain F0608, which was newly isolated from soil. I discovered that. Next, an acyl-coenzyme A cholesterol acyltransferase inhibitory substance was isolated and purified from the culture, and as a result, this substance was classified as FO160B substance B, since no substance with such a chemical structure was previously known.
and F0608C substance.

本発明はかかる知見に基いて完成されたものであって、
式 で表されるFO−608B物質および で表されるFO−608C物質からなる群より選ばれた
FO−608物質類またはその塩を提供するものである
The present invention was completed based on such knowledge, and
The present invention provides FO-608 substances selected from the group consisting of the FO-608B substance represented by the formula and the FO-608C substance represented by the formula or a salt thereof.

更に、本発明はペニシリウム属に属し、FO−608B
物質および/またはFO−608C物質を生産する能力
を有する微生物を培地に培養して培養物にFO−608
B物質および/またはFO−608C物質を蓄積せしめ
、該培養物からFO−608B物質および/またはFO
−608C物質を採取することを特徴とするFO−60
8B物質および/FO608C物質あるいはそれらの塩
の製造法を提供するものである。
Furthermore, the present invention belongs to the genus Penicillium, and FO-608B
FO-608C substance and/or microorganisms capable of producing the FO-608C substance are cultured in a culture medium to form a culture with FO-608C substance.
FO-608B substance and/or FO-608C substance are accumulated from the culture.
-FO-60 characterized by collecting 608C substance
The present invention provides a method for producing 8B substance and /FO608C substance or salts thereof.

FO−608B物質および/またはFO−608C物質
を生産する能力を有する微生物(以下、FO608物質
生産菌と称する)は、ペニシリウム属に属するが、例え
ば本発明者らが分離したペニシリウム属に属するFO−
608菌株は、本発明の最も有効に使用される菌株の一
例であって、本菌株の菌学的性状を示すと次の通りであ
る。
Microorganisms having the ability to produce the FO-608B substance and/or the FO-608C substance (hereinafter referred to as FO608 substance-producing bacteria) belong to the genus Penicillium.
The 608 strain is an example of the strain most effectively used in the present invention, and the mycological properties of this strain are as follows.

本発明のFO”−6’08B物質および/またはFO6
08C物質(以下、総称してFO−608物質と総称し
ていう)を生産するために使用される菌株としては、例
えば本発明者らによって土壌から分離されたペニシリウ
ム エスピー、  (Penicil] ium  s
p、)FO−608株が挙げられる。
FO"-6'08B substance and/or FO6 of the present invention
Examples of bacterial strains used to produce 08C substances (hereinafter collectively referred to as FO-608 substances) include Penicillium sp., which was isolated from soil by the present inventors.
p, ) FO-608 strain.

■、形態学的性質 本菌株は麦芽汁寒天培地、バレイショ・ブドウ糖づ 寒天培地、ツアペック寒天培地、オートミール寒天培地
、Y p S、 s寒天培地などで比較的良好に生育し
、分生子の着生も良好である。ツアペック寒天培地に生
育したコロニーを顕微鏡で観察すると、菌糸は透明で隔
壁を有しており、分生子柄は基底菌糸より直生じ、その
表面は滑面である。ベニシラスはメト−とフィアライド
から構成される複輪生体一対称型である。メト−の大き
さは9〜11×2〜2.5μで3〜6個着生する。フィ
アライドはペン先型で3〜6個群生し、大きさは10〜
1’4X0.9〜1゜7μmである。
■ Morphological properties This strain grows relatively well on wort agar, potato-dextrose agar, Czapek agar, oatmeal agar, Y p S, S agar, etc., and does not exhibit conidial settlement. is also good. When a colony grown on a Zapek agar medium is observed under a microscope, the hyphae are transparent and have septa, the conidiophores arise directly from the basal hyphae, and their surfaces are smooth. Benicillus is a double-wheeled, monosymmetric type consisting of metho and phialide. The size of the methos is 9-11 x 2-2.5μ and 3-6 pieces are attached. Phialides are pen-shaped and grow in clusters of 3 to 6 pieces, and the size is 10 to 10.
1'4×0.9 to 1°7 μm.

はじめはフィアロ型分生子がフィアライドの頂端に1個
着生し、培養時間の経過とともに連鎖状となり、最終的
にはこの連鎖は150μm前後に達する。
At first, one phialoid conidia settles on the apex of the phialide, and as the culture time progresses, it forms a chain, and eventually this chain reaches around 150 μm.

電子顕微鏡で観察すると、分生子はだ円形で、大きさは
2.5〜3X1.8〜2.2μmであり、その表面は滑
面である。
When observed under an electron microscope, the conidia are oval in shape, measuring 2.5-3 x 1.8-2.2 μm, and have a smooth surface.

■、培養上の諸性状 (]、)各種培地上で25℃、12日間培養した場合の
肉眼的観察結果を第1表に示す。
(2) Various properties on culture (],) Table 1 shows the results of macroscopic observation when cultured on various media at 25°C for 12 days.

(2)上記培地における37℃、12日間培養した場合
の生育状態は、抑制的(コロニー直径20〜30m m
 )で、菌糸は拡散せず、ビロード状であった。
(2) When cultured in the above medium at 37°C for 12 days, the growth state was suppressive (colony diameter 20-30 mm).
), the hyphae were not diffused and velvety.

又、5℃、12日間培養した場合の生育状態は、きわめ
て抑制的(10mm以下)で、分生子は形成しなかた。
Furthermore, when cultured at 5° C. for 12 days, the growth state was extremely suppressed (10 mm or less), and no conidia were formed.

前記のすべての培地には菌の生育に伴う分泌液および菌
核の形成は観察されなかった。
In all of the above-mentioned media, secretion and sclerotia formation accompanying bacterial growth were not observed.

■、生理的、生態的性状 +1)最適生育条件 本菌株の最適生育条件は、麦芽汁寒天培地においてpH
4〜7、温度18〜33°Cである。
■, Physiological and ecological properties + 1) Optimal growth conditions The optimal growth conditions for this strain are wort agar medium with pH
4-7, temperature 18-33°C.

(2)生育の範囲 本菌株の生育範囲は、麦芽汁寒天培地においてpH2〜
9、温度15〜39℃である。
(2) Growth range The growth range of this strain is from pH 2 to 2 on wort agar medium.
9. The temperature is 15-39°C.

(3)好気性、嫌気性の区別 好気性 以上の諸性状中、形態観察の結果から本菌株がペニシリ
ウム属に属することが明らかとなった。
(3) Distinction between aerobic and anaerobic Among the various properties beyond aerobic, morphological observation revealed that this strain belongs to the genus Penicillium.

なお、本菌株はペニシリウム エスピー、FO608(
Penicillium   sp、  FO−608
)として工業技術院微生物工業技術研究所に寄託されて
いる。(FERM  l”10776号)。
This strain is Penicillium sp., FO608 (
Penicillium sp, FO-608
) has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology. (FERM l” No. 10776).

以上、FO−608B物質およびFO−608C物質生
産菌について説明したが、菌の一般的性状として蘭学上
の性状はきわめて変異し易り、一定したものではなく、
自然的にあるいは通常行われる紫外線照射または変異誘
導体、例えばN−メチル−Nニトロ−N−ニトロソグア
ニジン、エチルメタンスルホネートなどを用いる人工的
変異手段により変異することは周知の事実であり、この
ような人工的変異株は勿論、自然変異株も含め、ペニシ
リウ1、属に属し、FO−608B物質およびFO−6
08C物質を生産する能力を有する菌株はすべて本発明
に使用することができる。また、細胞融合、遺伝子操作
などの細胞工学的に変異させた菌株も物質FO−608
物質生産菌として包含される。
The bacteria that produce the FO-608B substance and FO-608C substance have been explained above, but as a general property of bacteria, the properties according to Dutch science are extremely variable and are not constant.
It is a well-known fact that mutations occur naturally or by artificial mutation means using conventional ultraviolet irradiation or mutation derivatives such as N-methyl-Nnitro-N-nitrosoguanidine, ethyl methanesulfonate, etc. Not only artificial mutant strains but also natural mutant strains belong to the genus Penicillium 1, and the FO-608B substance and FO-6
Any strain capable of producing 08C substances can be used in the present invention. In addition, strains mutated through cell engineering such as cell fusion and genetic manipulation can also be used as a substance.
Included as substance-producing bacteria.

本発明においては、先ずペニシリウムに属するFO−6
08B物質およびFO−608C物質生産菌が培地に培
養される。本菌の培養においては、通常真菌の培養法が
一般に用いられる。培地としては、微生物が同化し得る
炭素源、資化し得る窒素源、さらには必要に応じて無機
酸塩などを含有させた栄養培地が使用される。同化し得
る炭素源としては、ブドウ糖、ショ糖、糖蜜1、デキス
トリン、セルロスなどが単独または組み合わせて用いら
れる。資化し得る窒素源としては、ペプトン、肉エキス
、酵母エキス、乾燥酵母、大豆粉、コーン・ステープ・
リカー、綿実粕、カゼイン、大豆蛋白加水分解物、アミ
ノ酸、尿素などの有機窒素源、硝酸塩、アンモニウム塩
などの無機窒素化合物が単独または組み合わせて用いら
れる。その他、必要に応じてすトリウム塩、カリウム塩
、カルシウム塩、マグネシウム塩、リン酸塩などの無機
塩、重金属塩類が添加される。
In the present invention, first, FO-6 belonging to Penicillium
08B substance and FO-608C substance producing bacteria are cultured in a medium. In culturing this bacterium, a normal fungal culture method is generally used. As the medium, a nutrient medium containing a carbon source that can be assimilated by microorganisms, a nitrogen source that can be assimilated by microorganisms, and, if necessary, an inorganic acid salt is used. As assimilable carbon sources, glucose, sucrose, molasses 1, dextrin, cellulose, etc. are used alone or in combination. Nitrogen sources that can be assimilated include peptone, meat extract, yeast extract, dried yeast, soy flour, corn staple,
Organic nitrogen sources such as liquor, cottonseed meal, casein, soybean protein hydrolyzate, amino acids, urea, and inorganic nitrogen compounds such as nitrates and ammonium salts are used alone or in combination. In addition, inorganic salts and heavy metal salts such as thorium salts, potassium salts, calcium salts, magnesium salts, and phosphates are added as necessary.

さらに、培地には、必要に応して、本菌の生育やFO−
608B物質およびFO−608C物質の生産を促進す
る微量栄養素、発育促進物質、前駆物質などを適当に添
加してもよい。
Furthermore, the culture medium may contain FO-
Micronutrients, growth promoters, precursors, etc. that promote the production of 608B and FO-608C substances may be added as appropriate.

培養は通常振とうまたは通気攪拌培養などの好気的条件
下で行うのがよい。工業的には深部通気攪拌培養が好ま
しい。培養のpHは中性付近で培養を行うのが好ましい
。培養温度は20〜37℃で行い得るが、通常は24〜
30℃に保つのがよい。培養時間は液体の場合、通常2
〜3日培養を行うと、木FO−608BおよびFO−6
08C物質が蓄積されるので、培養中の蓄積量が最大に
達した時に、培養を終了すればよい。これらの培地組成
、培地の液性、培養温度、培養速度、通気量などの培養
条件は使用する菌株の種類や外部の条件などに応して好
ましい結果が得られるように適宜調節、選択されるごと
はいうまでもない。液体培養において、発泡があるとき
は、シリコン油、植物油、界面活性剤などの消泡剤を適
宜使用できる。 このようにして得られた培養物に蓄積
されるPCI−608B物質およびFO608C物質は
菌体内および培養濾液中に含有されるので、培養物を遠
心分離して培養濾液と菌体とに分離し、各々から零FO
−608B物質およびFO)−6080物質を採取する
のが有利である。
Cultivation is usually carried out under aerobic conditions such as shaking or aerated agitation culture. Industrially, deep aeration agitation culture is preferred. It is preferable to culture at a pH around neutrality. The culture temperature can be 20-37°C, but usually 24-37°C.
It is best to keep it at 30°C. Incubation time is usually 2 if using liquid.
When cultured for ~3 days, trees FO-608B and FO-6
Since the 08C substance accumulates, the culture may be terminated when the amount accumulated during culture reaches the maximum. These culture conditions such as medium composition, medium liquid properties, culture temperature, culture speed, and aeration amount are adjusted and selected as appropriate to obtain favorable results depending on the type of bacterial strain used and external conditions. Needless to say. When foaming occurs in liquid culture, antifoaming agents such as silicone oil, vegetable oil, and surfactants can be used as appropriate. Since the PCI-608B substance and FO608C substance accumulated in the culture thus obtained are contained in the bacterial cells and the culture filtrate, the culture is centrifuged to separate the culture filtrate and the bacterial cells, Zero FO from each
-608B material and FO) -6080 material is advantageously taken.

培養濾液からF、C)−608物質およびFO−608
C物質を採取するには、先ず培養濾液を酢酸エチ1 2 ル、酢酸ブチル、ベンゼンなどの非親水性有機溶媒で抽
出し、抽出液を減圧濃縮して粗製のFO−608B物質
およびFO−608C物質が得られる。該粗製物質はさ
らに脂溶性物質の精製に通常用いられる公知の方法、例
えばシリカゲル、アルミナなどの担体を用いるカラムク
ロマトグラフィーにより各々FO−608B物質および
FO−608C物質を分離精製することができる。
F, C)-608 substances and FO-608 from culture filtrate
To collect substance C, first, the culture filtrate is extracted with a non-hydrophilic organic solvent such as ethyl acetate, butyl acetate, or benzene, and the extract is concentrated under reduced pressure to obtain crude FO-608B substance and FO-608C. Substances are obtained. The crude substance can be further separated and purified into the FO-608B substance and the FO-608C substance by a known method commonly used for purifying fat-soluble substances, such as column chromatography using a carrier such as silica gel or alumina.

菌体からPCI−608B物質およびFO−608C物
質を採取するには、菌体を含水アセトン、含水メタノー
ルなどの含水親水性有機溶媒で抽出し、得られた抽出液
を減圧濃縮し、その濃縮物を酢酸エチル、酢酸ブチル、
ベンゼンなどの非親水性有機溶媒で抽出し、得られた抽
出液は、前記の培養濾液から得た抽出液と合わせて分離
精製するか、あるいは前記同じ方法により各々FO)−
608B物質およびFO−608C吻質を分離精製する
ことができる。
To collect PCI-608B and FO-608C substances from bacterial cells, the bacterial cells are extracted with a hydrophilic organic solvent containing water such as aqueous acetone and methanol, and the resulting extract is concentrated under reduced pressure. ethyl acetate, butyl acetate,
Extraction is performed with a non-hydrophilic organic solvent such as benzene, and the resulting extract is combined with the extract obtained from the culture filtrate and separated and purified, or the same method as described above is used to separate and purify each FO)-
608B substance and FO-608C proboscis can be separated and purified.

次に、本発明のFO−608B物質およびFO608C
物質の理化学的性状について述べる。
Next, the FO-608B substance and FO608C of the present invention
Describe the physical and chemical properties of substances.

(1)FO−608B物質 (1)分子式:CzsHzbC)r  (高分解能スペ
クトルでm/z414が観察さ れた) (2)分子量:4’14(マススペクトルよりm/z4
14 (M” )が観察された) (3)比旋光度: 〔α)20−+355.6 (C=
1゜クロロホルム) (4)紫外線吸収スペクトル(エタノール中):第1図
の通り (5)赤外線吸収スペクトル(四塩化炭素中):第3図
の通り (6)溶媒に対する溶解性 :メタノール、エタノール、アセトニ トリル、酢酸エチル、ベンゼンに可 溶、水に不溶 (7)塩基性、酸性、中性の区別 :中性 (8)物質の色、形状 :黄色粉末 (9)プロトン核磁気共鳴スペクトル(重クロロホルム
中) :第5図の通り 001化学構造: (2) FO−608C物質 111分子式: C2:1H2407(高分解能スペク
トルでm/2412が観察さ れた) (2)分子量:412 (マススペクトルよりm/z4
12 (M” )が観察された) (3)比旋光度: 〔α〕皆−十476.2 (C=1
゜クロロホルム) (4)紫外線吸収スペクトル(エタノール中):第2図
の通り (5)赤外線吸収スペクトル(四塩化炭素中):第4図
の通り (6)溶媒に対する熔解性 :メタノール、エタノール、アセトニ トリル、酢酸エチル、ベンゼンに可 ?容、水に不?容 (7)塩基性、酸性、中性の区別 :中性 (8)物質の色、形状 :黄色粉末 (9)プロトン核磁気共鳴スペクトル(重クロロホルム
中) :第6図の通り Q19化学構造: 5 6 次に、本発明のFO−608B物質およびFO608C
物質の生物学的性状および毒性について述べる。
(1) FO-608B substance (1) Molecular formula: CzsHzbC)r (m/z 414 was observed in the high-resolution spectrum) (2) Molecular weight: 4'14 (m/z 4 from the mass spectrum)
14 (M”) was observed) (3) Specific optical rotation: [α)20-+355.6 (C=
(1° chloroform) (4) Ultraviolet absorption spectrum (in ethanol): As shown in Figure 1 (5) Infrared absorption spectrum (in carbon tetrachloride): As shown in Figure 3 (6) Solubility in solvents: methanol, ethanol, Soluble in acetonitrile, ethyl acetate, benzene, insoluble in water (7) Basic, acidic, neutral: neutral (8) Color and shape of substance: yellow powder (9) Proton nuclear magnetic resonance spectrum (deuterochloroform (middle): 001 chemical structure as shown in Figure 5: (2) FO-608C substance 111 molecular formula: C2:1H2407 (m/2412 was observed in the high-resolution spectrum) (2) Molecular weight: 412 (m/2412 from the mass spectrum) z4
12 (M”) was observed) (3) Specific optical rotation: [α] Min-1476.2 (C=1
(4) Ultraviolet absorption spectrum (in ethanol): As shown in Figure 2 (5) Infrared absorption spectrum (in carbon tetrachloride): As shown in Figure 4 (6) Solubility in solvents: methanol, ethanol, acetonitrile , ethyl acetate, benzene? Is it bad for water? (7) Distinction between basic, acidic, and neutral: Neutral (8) Color and shape of substance: Yellow powder (9) Proton nuclear magnetic resonance spectrum (in deuterium chloroform): Q19 chemical structure as shown in Figure 6: 5 6 Next, the FO-608B substance and FO608C of the present invention
Describe the biological properties and toxicity of the substance.

アシルコエンザイムAコレステロールアシル転位酵素活
性に対する影響はラット肝ミクロソーム画分より調整し
た粗酵素を用い300μM (1−14C)01eoy
l−CoA;3mg/m7!コレステロールを各々20
μJ (0,02μ42ci);6.67μ!添加し3
7゛Cで30分間反応させ、総脂質をクロロホルJ1:
メタノール(2: 1)混合液で抽出後、TLC(キー
ゼルゲルGF2S4、展開溶媒として石油エーテル:ジ
エチルエーテル:酢酸、90:10:1)で各脂質を分
離後、コレステロールエステル画分をかきとり、液体シ
ンチレーションカウンターでアジルコエンザイムAコレ
ステロールアシル転位酵素活性を測定した。本酵素に対
する50%阻害する濃度を算定した結果はFO−608
B物質は50μg/mp、、FO−608C物質は52
μg/m7!であった。
The effect on acyl-coenzyme A cholesterol acyltransferase activity was determined using crude enzyme prepared from rat liver microsomal fraction at 300 μM (1-14C)01eoy.
l-CoA; 3mg/m7! 20 each of cholesterol
μJ (0,02μ42ci); 6.67μ! Added 3
React at 7°C for 30 minutes, and convert total lipids to chlorophor J1:
After extraction with a methanol (2:1) mixture, each lipid was separated using TLC (Kieselgel GF2S4, petroleum ether:diethyl ether:acetic acid, 90:10:1 as a developing solvent), and the cholesterol ester fraction was scraped off and subjected to liquid scintillation. Azylcoenzyme A cholesterol acyltransferase activity was measured using a counter. The results of calculating the concentration that inhibits this enzyme by 50% are FO-608
B substance is 50μg/mp, FO-608C substance is 52
μg/m7! Met.

(2)毒性 FO−608B物質およびFO−608C物質各々10
0mg/kgをマウス腹腔内に投与したが、何ら毒性変
化は認められなかった。
(2) Toxic FO-608B substance and FO-608C substance 10 each
Although 0 mg/kg was administered intraperitoneally to mice, no toxic changes were observed.

以上のように、本発明のFO−608B物質およびFO
−608C物質は毒性が低く、アシルコエンザイ1、A
コレステロールアシル転位酵素に対して著しい阻害活性
を示すことから、ヒトのコレステロール蓄積に起因する
疾病の予防および治療に有用であると考える。
As described above, the FO-608B substance of the present invention and FO
-608C substance has low toxicity, acylcoenzyme 1, A
Since it shows remarkable inhibitory activity against cholesterol acyltransferase, it is considered to be useful for the prevention and treatment of diseases caused by cholesterol accumulation in humans.

次に実施例を挙げて本発明を具体的に説明する。Next, the present invention will be specifically explained with reference to Examples.

〔実施例〕〔Example〕

500mβ容三角フラスコにグルコース0.1%、スタ
ーチ2.4%、ペプトン0.3%、肉エキス0.3%、
イーストエキストラクト0.5%、炭酸カルシウム0.
4%を含む培地(pH7,0に調整)100mffを仕
込み、綿栓後、蒸気滅菌し、寒天培地上に生育させたペ
ニシリウム エスピー、FO608(FERM  P−
10776>を白金耳にて無菌的に接種し、27℃で4
8時時間表う培養して種培養液を得た。
In a 500mβ Erlenmeyer flask, glucose 0.1%, starch 2.4%, peptone 0.3%, meat extract 0.3%,
Yeast extract 0.5%, calcium carbonate 0.
Penicillium sp., FO608 (FERM P-
10776> was aseptically inoculated using a platinum loop, and incubated at 27℃ for 4 hours.
A seed culture solution was obtained by culturing for 8 hours.

一方、50rジャーファーメンタ−1基にグルコ−7!
、1.0%、クリセロール3%、ペプトン0.5%、塩
化ナトリウム0.2%、寒天0.1%(pH7,0に調
整)に仕込み、蒸気滅菌冷却後、種培養した種培養液2
00m1lを無菌的に移植し、攪拌速度250rpm、
通気量10β/分の培養条件下で27℃で44時間通気
攪拌した。
On the other hand, Gluco-7 in one 50r jar fermenter!
, 1.0%, Chrycerol 3%, peptone 0.5%, sodium chloride 0.2%, agar 0.1% (adjusted to pH 7.0), steam sterilized and cooled, and then seed cultured.
00ml was transplanted aseptically, stirring speed 250 rpm,
The mixture was aerated and stirred at 27° C. for 44 hours under culture conditions with an aeration rate of 10 β/min.

培養後、培養液30βを酢酸エチル18/で抽出し、抽
出液を減圧濃縮して粗製物を得た。この粗製物をシリカ
ゲル(250g、メルク社製、Art。
After culturing, the culture solution 30β was extracted with 18% ethyl acetate, and the extract was concentrated under reduced pressure to obtain a crude product. This crude product was mixed with silica gel (250 g, manufactured by Merck & Co., Ltd., Art.

9385)のカラムにチャージし、n−ヘキサン酢酸エ
チル(4:1〜2:1)で溶出するカラムクロマトグラ
フィーを行った。各フラクションは100mβづつ分画
し、活性成分を含むフラクションを集め、減圧乾固して
粗活性物質1.5gを得た。これを5回に分けて高速液
体クロマトグラフィーにより分離精製した。装置はトリ
ロータV(日本分光社製)を用い、カラムはYMC−P
ack  A−343(ODS系樹脂、山村化学研究所
型)を用い、溶媒系は、65%のアセトニトリル水を用
い、検出はUV280nm、流速は8 m lI 7分
で行った。その結果FO−608B物質40mg、FO
−608C物質550mgを単離した。
Column chromatography was performed by charging a column of 9385) and eluting with n-hexane ethyl acetate (4:1 to 2:1). Each fraction was divided into 100 mβ fractions, and the fractions containing the active ingredient were collected and dried under reduced pressure to obtain 1.5 g of the crude active substance. This was separated and purified by high performance liquid chromatography in 5 parts. The device used is Trirotor V (manufactured by JASCO Corporation), and the column was YMC-P.
Ack A-343 (ODS resin, Yamamura Kagaku Institute type) was used, the solvent system was 65% acetonitrile water, detection was performed at UV 280 nm, and the flow rate was 8 ml 7 minutes. As a result, 40 mg of FO-608B substance, FO
550 mg of -608C material was isolated.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はFO−608’B物質の紫外線吸収スペク1〜
ル、第2図はFO−608C物質の紫外線吸収スペクト
ル、第3図はFO−608B物質の赤外線吸収スペクト
ル、第4図はFO−608C物質の赤外線吸収スペクト
ル、第5図はFO−608B物質のプロトン核磁気共鳴
スペク1−ル、第6図はFO−608C物質のプロトン
核磁気共鳴スペクトルを示す。 9 2 〇− 特開平 3 197477 (8ン  C 区 区 6り
Figure 1 shows the ultraviolet absorption spectra of FO-608'B material.
Figure 2 is the ultraviolet absorption spectrum of the FO-608C material, Figure 3 is the infrared absorption spectrum of the FO-608B material, Figure 4 is the infrared absorption spectrum of the FO-608C material, and Figure 5 is the infrared absorption spectrum of the FO-608B material. Proton Nuclear Magnetic Resonance Spectrum Figure 6 shows the proton nuclear magnetic resonance spectrum of the FO-608C material. 9 2 〇- Unexamined Japanese Patent Publication No. 3 197477 (8n C ward 6ri

Claims (1)

【特許請求の範囲】 (1)式 ▲数式、化学式、表等があります▼ で表されるFO−608B物質および式 ▲数式、化学式、表等があります▼ で表されるFO−608C物質からなる群より選ばれた
FO−608物質またはその塩。(2)ペニシリウム属
に属し、FO−608B物質および/またはFO−60
8C物質を生産する能力を有する微生物を培地に培養し
て培養中にFO−608B物質および/またはFO−6
08C物質を蓄積せしめ、該培養物からFO−608B
物質および/またはFO−608C物質を採取すること
を特徴とするFO−608B物質および/またはFO−
608C物質あるいはそれらの塩の製造法。 (3)ペニシリウム属に属し、FO−608B物質およ
び/またはFO−608C物質を生産する能力を有する
微生物がペニシリウムエスピー.FO−608(Pen
icilliumsp.FO−608FERMP−10
776である請求項2記載の製造法。 (4)ペニシリウム属に属し、FO−608B物質およ
び/またはFO−608C物質を生産する能力を有する
微生物。 (5)微生物がペニシリウム・エスピー.FO−608
である請求項4記載の微生物。
[Claims] (1) Consists of the FO-608B substance represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ and the FO-608C substance represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ FO-608 substance or a salt thereof selected from the group. (2) FO-608B substance and/or FO-60 belonging to the genus Penicillium;
FO-608B substance and/or FO-6 during culture by culturing a microorganism capable of producing 8C substance in a medium.
08C material was allowed to accumulate and FO-608B was removed from the culture.
FO-608B substance and/or FO-608B substance and/or FO-608C substance characterized by collecting the substance and/or FO-608C substance
Method for producing 608C substances or their salts. (3) Microorganisms belonging to the genus Penicillium and having the ability to produce the FO-608B substance and/or the FO-608C substance are Penicillium sp. FO-608 (Pen
icilium sp. FO-608FERMP-10
776. The manufacturing method according to claim 2. (4) A microorganism belonging to the genus Penicillium and having the ability to produce a substance FO-608B and/or a substance FO-608C. (5) The microorganism is Penicillium sp. FO-608
The microorganism according to claim 4.
JP1337092A 1989-12-26 1989-12-26 FO-608B, C substance and method for producing the same Expired - Lifetime JP2872311B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1337092A JP2872311B2 (en) 1989-12-26 1989-12-26 FO-608B, C substance and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1337092A JP2872311B2 (en) 1989-12-26 1989-12-26 FO-608B, C substance and method for producing the same

Publications (2)

Publication Number Publication Date
JPH03197477A true JPH03197477A (en) 1991-08-28
JP2872311B2 JP2872311B2 (en) 1999-03-17

Family

ID=18305359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1337092A Expired - Lifetime JP2872311B2 (en) 1989-12-26 1989-12-26 FO-608B, C substance and method for producing the same

Country Status (1)

Country Link
JP (1) JP2872311B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039364A1 (en) * 2002-10-31 2004-05-13 Bayer Healthcare Ag Novel use of dioxocin-5-on derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039364A1 (en) * 2002-10-31 2004-05-13 Bayer Healthcare Ag Novel use of dioxocin-5-on derivatives

Also Published As

Publication number Publication date
JP2872311B2 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
JP3233476B2 (en) FO-1289 substance and method for producing the same
JP2993767B2 (en) FO-1289A substance and method for producing the same
JPH10287662A (en) Fo-5637a and b substance, and their production
JPH08239385A (en) Fo-1289 substance and its production
JP2710834B2 (en) FO-608A substance and method for producing the same
JP4160149B2 (en) Novel FO-6969 substance and process for producing the same
JPH03197477A (en) Substances fo-608b and c and its production
JP3074038B2 (en) FO-1513A substance and method for producing the same
JP4380913B2 (en) Novel FT-0554 substance and production method thereof
JP3434860B2 (en) FO-2546 substance and method for producing the same
EP0952227B1 (en) A bio-resolution process
JP2002275194A (en) New fo-6979-m0 substance, fo-6979-m1 substance, fo-6979-m2 substance, fo-6979-m3 substance and fo-6979-m4 substance and method for producing the same
JPH07242636A (en) Fo-3216 substance and its production
JPH03227971A (en) Carbazole compound
JP3580875B2 (en) FO-4259 substance and method for producing the same
JP2748273B2 (en) New antibiotic PF1015 substance and its production method
JPH0856688A (en) Substance fo-2546 and its production
JPH041179A (en) Antitumor substance be-14106
JPH0532656A (en) Decalin-based compound
JPS6143182A (en) Novel antibiotic ss19508d and preparation thereof
JPS62228074A (en) Substance ss50408 and production thereof
JPS6269992A (en) Antibiotic ss42227a and production thereof
JPS6135788A (en) Physiologically active substance ss20846a and its preparation
JPH0446188A (en) New antibiotic pf1032b substance and production thereof
JPS60260570A (en) Novel antibiotic substance ss19508b and its preparation